Merck KGaA, Darmstadt, Germany, Enters into Option Agreement with Quris on its BioAI…
BOSTON and TEL-AVIV, Israel, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced it has signed an…